Directing p53 to induce autophagy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

1. Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.The Journal of physiology · 2018
   Article
2. AMPK is required for PM2.5-induced autophagy in human lung epithelial A549 cells.International journal of clinical and experimental medicine · 2015
   Article
3. Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53.Cell cycle (Georgetown, Tex.) · 2013
   Article

Corrections and comments

• Comment on
  PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy.2012

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as